ArticleScience advances2021

Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.

Supriya Ravichandran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.